Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial

European Journal of Cancer Care
R CorvòV Vitale

Abstract

Fluconazole is recommended in the prophylaxis of oropharyngeal candidiasis (OPC) in patients undergoing radiotherapy for head-neck tumours; however, the actual effectiveness of fluconazole in this setting remains unclear. Adult patients with cervico-cephalic carcinoma submitted to radical or adjuvant radiotherapy were randomized to 100 mg fluconazole (n = 138) or matched placebo (n = 132) oral suspension once daily from the sixth session of radiotherapy up to the end of treatment. The final analysis of the investigation showed a higher rate of the OPC outbreak-free survival in the fluconazole compared with placebo (P = 0.008 in the log-rank test). The mean time (95% CI) to OPC outbreak was 56 (53-59) days in the fluconazole group and 47 (43-51) days with placebo. The mean duration of radiotherapy was 43.5 and 39.9 days, respectively in the two groups (P = 0.027). Adverse effects were reported in 70.3% of patients in the fluconazole group and in 67.4% with placebo. The results showed prophylaxis with fluconazole given in irradiated patients with head-neck tumours significantly reduces the rate and the time to development of OPC compared with placebo.

References

Dec 1, 1987·Oral Surgery, Oral Medicine, and Oral Pathology·K M RossieG G Blozis
Feb 1, 1984·AORN Journal·S S Klann, P N Palmer
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·J OliaryN Brion
Aug 1, 1997·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·V Ramirez-AmadorJ Quivey
Jul 11, 1998·Oral Oncology·W ParulekarR C Jordan
Oct 9, 1998·Acta Odontologica Scandinavica·J BlomgrenM Jontell
May 1, 2002·Journal of Clinical Microbiology·Spencer W ReddingThomas F Patterson
Mar 12, 2003·Japanese Journal of Clinical Oncology·Mehmet Koc, Esin Aktas
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Marta C DahiyaCharles R Thomas
Sep 2, 2003·Japanese Journal of Clinical Oncology·Masanori SomeyaMasato Hareyama
Jun 5, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A M L Oude LashofUNKNOWN EORTC Invasive Fungal Infections Group

❮ Previous
Next ❯

Citations

Apr 12, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rene-Jean BensadounJoel B Epstein
Feb 26, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paolo BossiElvio Russi
Sep 11, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Ana MañasUNKNOWN Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
Jul 9, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Deborah P SaundersUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Jul 6, 2010·Dermatologic Therapy·Victoria Sharon, Nasim Fazel
Aug 13, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mario BusettoLuciana Lastrucci
Jun 10, 2009·Expert Opinion on Pharmacotherapy·Joel M Laudenbach, Joel B Epstein
Feb 14, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Deborah P SaundersUNKNOWN Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (
Jan 27, 2007·The Cochrane Database of Systematic Reviews·J E ClarksonO B Eden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Rajesh V LallaFungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/Internation
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Jacqueline A E LangiusMarian A E van Bokhorst-de van der Schueren
International Journal of Radiation Oncology, Biology, Physics
Joseph GligorovCandidoscope Study Group
© 2022 Meta ULC. All rights reserved